Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Omar Ishrak
AddedFeb 19, 2024
UpdatedMay 31, 2026
Omar Ishrak

Omar Ishrak

Board Member, Intel Capital

CrunchbaseLinkedInThe Org

Omar Ishrak's Career

Intel Capital
Intel Capital

Santa Clara, CA, US

Board Member· Board
Minnesota Public Radio
Minnesota Public Radio

Saint Paul, MN, US

Board Member· Board
Biofourmis
Biofourmis

Boston, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Omar Ishrak's Career

Intel Capital
Intel Capital
Investment FirmInvestment Firm$12.5M131.9k1968Santa Clara, CA, US
Board Member· Board

Recent news

Figure reaches $39B valuation in latest funding roundTechCrunch · 2025
FieldAI raises $405M to build universal robot brainsTechCrunch · 2025
Portable X-ray vision is one step closer to reality with OXOS MedicalTechCrunch · 2023

Leadership at Intel Capital

Alyssa HenryAlyssa HenryBoard Member
Tore SteenTore SteenBoard Member
Gordon MooreGordon MooreCo-Founder
Pat GelsingerPat GelsingerBoard Member
Jim GoetzJim GoetzBoard Member
Avram MillerAvram MillerFounder
Minnesota Public Radio
Minnesota Public Radio
3201967Saint Paul, MN, US
Board Member· Board

Leadership at Minnesota Public Radio

Nancy LyonsNancy LyonsBoard Member
Mary BrainerdMary BrainerdBoard Member
Jon McTaggartJon McTaggartCEO
Jim DwyerJim DwyerBoard Member
Richard MarcantonioRichard MarcantonioBoard Member
Bill McLaughlinBill McLaughlinBoard Member
Biofourmis
Biofourmis
Series D$463.6M3752015Boston, MA, US
Board Member· Board

Leadership at Biofourmis

Trevor FetterTrevor FetterBoard Member
Kuldeep Singh RajputKuldeep Singh RajputCo-Founder
Anvesh RamineniAnvesh RamineniBoard Member
Sachin H JainSachin H JainBoard Member
Mark Wendou NiuMark Wendou NiuCo-Founder
Maulik MajmudarMaulik MajmudarCo-Founder

Similar to Biofourmis

Heads Up HealthHeads Up HealthScottsdale, AZ, USAnalytics, Health Dataest. 2014Heads Up HealthScottsdale, AZ, US · est. 2014

Data analytics platform providing customizable health dashboards for individuals and healthcare professionals.

Seed · $3.1M42
BioTrillionBioTrillionSan Francisco, CA, USDigital Biomarkersest. 2018BioTrillionSan Francisco, CA, US · est. 2018

BioTrillion, a startup advancing healthcare through scalable digital biomarkers.

Seed · $2.3M15
InSyBioInSyBioNarragansett, RI, USBioinformatics, Softwareest. 2013InSyBioNarragansett, RI, US · est. 2013

InSyBio: A bioinformatics leader developing tools for personalized healthcare and complex biological data analysis.

Series A · $550k11
Biobot AnalyticsBiobot AnalyticsCambridge, MA, USWastewater Analyticsest. 2017Biobot AnalyticsCambridge, MA, US · est. 2017

Biobot Analytics: Transforming sewers into health observatories with analytics for better cities.

Series B · $28M104

Omar Ishrak's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Omar Ishrak

Jeremy RuskinJeremy RuskinBoard Member · InfoBionicScott J. DyllaScott J. DyllaBoard Member · Chimera BioengineeringAlberto YepezAlberto YepezCo-Founder · Forgepoint Capital ManagementJack BaderJack BaderBoard Member · XprizeIan NicholsonIan NicholsonBoard Member · LifearcChris MasonChris MasonBoard Member · Krystal Biotech